Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806479 · ClinicalTrials.gov registry record
Hypertrophic Cardiomyopathy Pilot Study
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 40
- Enrollment target
NCT02806479 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 40 participants.
The verdict
NCT02806479 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study evaluates mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy, in comparison to patients with well-understood arrhythmogenic substrate (ischemic cardiomyopathy), as well as to individuals free from arrhythmogenic substrate
Interventions
- OTHER Observational: Arrhythmogenic Substrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-09 |
| Est. Completion | 2020-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02806479
The ClinicalTrials.gov registry entry for NCT02806479 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational: Arrhythmogenic Substrate is the first listed.
NCT02806479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02806479 about?
NCT02806479 is a clinical study titled "Hypertrophic Cardiomyopathy Pilot Study". This study evaluates mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy, in comparison to patients with well-understood arrhythmogenic substrate (ischemic cardiomyopathy), as well as to individuals free from arrhythmogenic substrate
What is the current status of trial NCT02806479?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2016-09. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02806479?
The interventions under investigation include: Observational: Arrhythmogenic Substrate (OTHER).
Who is sponsoring clinical trial NCT02806479?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.